Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19: A Phase 2 Randomized Controlled Double-Blind Study
Description
CONCLUSIONS: In this trial of inhaled furosemide for COVID-19 respiratory failure, differences in Pao(2)/Fio(2) ratio to day 6 and other clinical outcomes were not significantly different, although the trial was underpowered due to early termination
